Volume 3 | Nature Reviews Drug Discovery
Phase II and Phase III attrition rates 2011–2012 | Nature Reviews Drug Discovery
Volume 19 | Nature Reviews Drug Discovery
Volume 15 | Nature Reviews Drug Discovery
Volume 20 Issue 2, February 2021
Nature Reviews Drug Discovery | CountryOfPapers
Article series : Nature Reviews Drug Discovery
The future of drug development: advancing clinical trial design | Nature Reviews Drug Discovery
Volume 21 Issue 11, November 2022
Volume 19 Issue 11, November 2020
The druggable genome | Nature Reviews Drug Discovery
Screening out irrelevant cell-based models of disease | Nature Reviews Drug Discovery
Can the pharmaceutical industry reduce attrition rates? | Nature Reviews Drug Discovery
Therapeutic targeting of the complement system | Nature Reviews Drug Discovery
THe LOnG pROCeSS OF DRuG DISCOVeRy FROm ORIGInAL IDeA (?) THROuGH THe... | Download Scientific Diagram
Nature Reviews - Nature Reviews Drug Discovery: Invasive fungal infections are a major medical concern, particularly in immunocompromised patients. In this Review, Perfect discusses the antifungal pipeline, including advances in the currently
Predicting in vivo drug interactions from in vitro drug discovery data | Nature Reviews Drug Discovery
PAASP publication in Nature Reviews Drug Discovery: Improving target assessment in biomedical research - the GOT-IT recommendations - paasp network
Optical biosensors in drug discovery | Nature Reviews Drug Discovery
Automating drug discovery | Nature Reviews Drug Discovery
A guide to drug discovery
Target deconvolution strategies in drug discovery | Nature Reviews Drug Discovery
Volume 13 | Nature Reviews Drug Discovery
Kinase drug discovery 20 years after imatinib | Nature Reviews Drug Discovery
